Experimental Virus Drug Remdesivir Failed In COVID-19 Human Trial

-YOMMY AYILARA. Experimental Virus Drug Remdesivir Failed In COVID-19 Human Trial. The experimental antiviral drug Remdesivir has failed in its first randomized clinical experiment to treat the COVID-19 illness. This was reported on Thursday 23rd April, 2020, referring to draft documents where it was accidentally published by the World Health Organization. Gilead Sciences, the company behind the medicine, disputed how the now deleted post had characterized the findings, saying the data showed a “potential benefit.” The Financial Times reported that researchers in China carried out a study on 237 patients,…

Read More